Semaglutide Helps Schizophrenia Patients Lose Weight Without Side Effects A study shows semaglutide helps with weight loss in schizophrenia without negatively affecting psychotic symptoms
Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders
Potential treatment for light sensitivity disorders Melanotan 1 has been investigated as a potential treatment for a variety of rare light sensitivity disorders, including: Xeroderma pigmentosum (XP), a rare condition that causes extreme sensitivity to ultraviolet (UV) light
Vyvgart Hytrulo represents the first novel, precision mechanism of action in more than 30 years for CIDP, a rare, debilitating neuromuscular disorder of the peripheral nervous system, according to argenxs press release
Typically, patients of our weight loss program in Austin, Texas who start FDA-approved GLP-1 medications like Ozempic and Wegovy lose an average 15% of their weight when combined with diet and exercise
Medium Chain Triglycerides (MCTs) : Rapidly absorbed and converted into energy by the liver, MCTs can increase the release of GLP-1 and peptide YY (PYY), another satiety hormone
